Option Care Health (OPCH) Gets a Buy from Truist Financial

Truist Financial analyst David S Macdonald reiterated a Buy rating on Option Care Health today and set a price target of $40.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, S Macdonald is a 5-star analyst with an average return of 10.8% and a 59.33% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Centene, CVS Health, and Tenet Healthcare.

In addition to Truist Financial, Option Care Health also received a Buy from J.P. Morgan’s Lisa Gill in a report issued on March 3. However, on February 25, TD Cowen maintained a Hold rating on Option Care Health (NASDAQ: OPCH).

Based on Option Care Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.47 billion and a net profit of $58.5 million. In comparison, last year the company earned a revenue of $1.35 billion and had a net profit of $60.13 million

Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OPCH in relation to earlier this year. Earlier this month, Michael Bavaro, the CHRO of OPCH sold 6,000.00 shares for a total of $198,000.00.